| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.8 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.018 | 0.8 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.8 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | -0.0071 | 0.8 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | 0.0078 | 0.8 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.0083 | 0.8 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | 0.0078 | 0.8 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | 0.0084 | 0.8 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.0079 | 0.8 |